Net Efficacy Adjusted for Risk (NEAR): A Simple Procedure for Measuring Risk:Benefit Balance

Open Access

Peer-reviewed

Research Article

José N. Boada ,

* E-mail: boadajuarez@gmail.com

Affiliation Clinical Pharmacology Unit, Pharmacovigilance Centre, University Hospital of Canary Islands, University of La Laguna, La Laguna, Santa Cruz de Tenerife, Spain
⨯
Carlos Boada,

Affiliation Clinical Pharmacology Unit, Pharmacovigilance Centre, University Hospital of Canary Islands, University of La Laguna, La Laguna, Santa Cruz de Tenerife, Spain
⨯
Mar García-Sáiz,
Marcelino García,

Affiliation Clinical Pharmacology Unit, Pharmacovigilance Centre, University Hospital of Canary Islands, University of La Laguna, La Laguna, Santa Cruz de Tenerife, Spain
⨯
Eduardo Fernández,

Affiliation Clinical Pharmacology Unit, Pharmacovigilance Centre, University Hospital of Canary Islands, University of La Laguna, La Laguna, Santa Cruz de Tenerife, Spain
⨯
Eugenio Gómez

Affiliation Clinical Pharmacology Unit, Pharmacovigilance Centre, University Hospital of Canary Islands, University of La Laguna, La Laguna, Santa Cruz de Tenerife, Spain
⨯

Reader Comments (1)

Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Statins
Is the Subject Area "Statins" applicable to this article?

Thanks for your feedback.
Thromboembolism
Is the Subject Area "Thromboembolism" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Cardiovascular therapy
Is the Subject Area "Cardiovascular therapy" applicable to this article?

Thanks for your feedback.